273 related articles for article (PubMed ID: 33080592)
1. Importance of microRNAs in Skin Oncogenesis and Their Suitability as Agents and Targets for Topical Therapy.
Gerloff D; Sunderkötter C; Wohlrab J
Skin Pharmacol Physiol; 2020; 33(5):270-279. PubMed ID: 33080592
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNAs in melanoma.
Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
[TBL] [Abstract][Full Text] [Related]
3. Aberrations in the micro-RNA biogenesis machinery and the emerging roles of micro-RNAs in the pathogenesis of cutaneous malignant melanoma.
Leibowitz-Amit R; Sidi Y; Avni D
Pigment Cell Melanoma Res; 2012 Nov; 25(6):740-57. PubMed ID: 22958787
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-221 and -222 pathway controls melanoma progression.
Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
[TBL] [Abstract][Full Text] [Related]
5. A Current Review on Drug Loaded Nanofibers: Interesting and Valuable Platform for Skin Cancer Treatment.
Mehan N; Kumar M; Bhatt S; Saini V
Pharm Nanotechnol; 2020; 8(3):191-206. PubMed ID: 31965948
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
[TBL] [Abstract][Full Text] [Related]
8. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA in non-melanoma skin cancer.
Sand M; Sand D; Altmeyer P; Bechara FG
Cancer Biomark; 2012; 11(6):253-7. PubMed ID: 23248183
[TBL] [Abstract][Full Text] [Related]
10. miRNAs in the Diagnosis and Prognosis of Skin Cancer.
Neagu M; Constantin C; Cretoiu SM; Zurac S
Front Cell Dev Biol; 2020; 8():71. PubMed ID: 32185171
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models.
Mishra RR; Kneitz S; Schartl M
Comp Biochem Physiol C Toxicol Pharmacol; 2014 Jun; 163():64-76. PubMed ID: 24462553
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer.
Lalotra AS; Singh V; Khurana B; Agrawal S; Shrestha S; Arora D
Curr Pharm Des; 2020; 26(44):5720-5731. PubMed ID: 32814523
[TBL] [Abstract][Full Text] [Related]
13. Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?
Tamas T; Baciut M; Nutu A; Bran S; Armencea G; Stoia S; Manea A; Crisan L; Opris H; Onisor F; Baciut G; Crisan B; Opris D; Bumbu B; Tamas A; Dinu C
Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946878
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound targeting of Q-starch/miR-197 complexes for topical treatment of psoriasis.
Lifshiz Zimon R; Lerman G; Elharrar E; Meningher T; Barzilai A; Masalha M; Chintakunta R; Hollander E; Goldbart R; Traitel T; Harats M; Sidi Y; Avni D; Kost J
J Control Release; 2018 Aug; 284():103-111. PubMed ID: 29870766
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in malignant melanoma.
Völler D; Ott C; Bosserhoff A
Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
[TBL] [Abstract][Full Text] [Related]
16. miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.
Neu J; Dziunycz PJ; Dzung A; Lefort K; Falke M; Denzler R; Freiberger SN; Iotzova-Weiss G; Kuzmanov A; Levesque MP; Dotto GP; Hofbauer GFL
PLoS One; 2017; 12(9):e0185028. PubMed ID: 28931048
[TBL] [Abstract][Full Text] [Related]
17. Advances in encapsulated dermal formulations in chemoprevention of melanoma: An overview.
Ravikumar P; Tatke P
J Cosmet Dermatol; 2019 Dec; 18(6):1606-1612. PubMed ID: 31436386
[TBL] [Abstract][Full Text] [Related]
18. Deep sequencing analysis of microRNA expression in human melanocyte and melanoma cell lines.
Ding N; Wang S; Yang Q; Li Y; Cheng H; Wang J; Wang D; Deng Y; Yang Y; Hu S; Zhao H; Fang X
Gene; 2015 Nov; 572(1):135-145. PubMed ID: 26164755
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA regulation of melanoma progression.
Bonazzi VF; Stark MS; Hayward NK
Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in Chemical Composition and Transdermal Delivery Systems for Topical Bio-actives in Skin Cancer.
Halder J; Mishra A; Kar B; Ghosh G; Rath G
Curr Top Med Chem; 2023; 23(1):31-43. PubMed ID: 36056871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
